Pacira

Pacira, founded in 2006, is a prominent pharmaceutical and healthcare company specializing in non-opioid pain management and regenerative health solutions. The firm is dedicated to advancing patient outcomes through innovative clinical developments and commercial manufacturing. By focusing on acute care and specialty pharmaceutical products, Pacira addresses critical medical needs while maintaining a commitment to societal well-being. Their flagship product, EXPAREL, exemplifies their focus on delivering effective, non-opioid alternatives for pain management in clinical settings.

Operating with 500-1,000 employees, Pacira maintains a robust operational footprint across eight locations. Learn about Pacira's global headquarters for detailed geographic information regarding their facilities in Brisbane, California. The company leverages a sophisticated infrastructure to support its commercial manufacturing and clinical research initiatives. Meet Pacira's team to gain insights into the leadership and organizational structure driving their mission to improve patient care and community health outcomes.

As a publicly traded entity on the NASDAQ under the ticker PCRX, Pacira demonstrates significant market presence within the healthcare sector. The company reported annual revenue of $734.9M, reflecting its strong position in the specialty pharmaceutical market. Explore financial highlights to review detailed metrics, funding history, and performance indicators. With a history of strategic growth and a focus on regulatory compliance, Pacira continues to compete effectively against industry peers like Chiesi USA, maintaining a clear focus on long-term value creation for stakeholders and patients alike.